Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Palindromic Rheumatism: Will It Progress to Severe Rheumatoid Arthritis?

Amaka Odonwodo, MD, MPH, & Carlos Julio Aponte, MD, FACP, FACR  |  Issue: October 2018  |  

Amaka Odonwodo, MD, MPH, recently completed her internal medicine residency at the Cleveland Clinic at Fairview Hospital in Cleveland. She is interested in rheumatology as a career path.

Carlos Julio Aponte, FACP, FACR, graduated from the National University of Colombia in 1968. He completed internal medicine residency in Cleveland, Ohio, and a rheumatology fellowship at the Cleveland Clinic. From 1975–2013, he practiced rheumatology mostly at Fairview Hospital in Cleveland, where he was chief of the Rheumatology Section of the Department of Medicine. His present title is chief of rheumatology emeritus. He continues to teach in many countries, most recently in Cambodia with Health Volunteers Overseas.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Guerne PA, Weisman MH. Palindromic rheumatism: Part of or apart from the spectrum of rheumatoid arthritis. Am J Med. 1992 Oct;93(4):451–460.
  2. Salvador G. Gomez A, Vinas O. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology (Oxford). 2003 Aug;42(8):972–975.
  3. Hannonen P, Müttönen T, Oka M. Palindromic rheumatism: A clinical survey of sixty patients. Scand J Rheumatol. 1987 Mar;16(6):413–420.
  4. Sanmarti R, Cabrera-Villalba S, Gomez-Puerta JA, et al. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J Rheumatol. 2012 Oct;39(10):1929–1933.
  5. Cabrera-Villalba S, Sanmartí R. Palindromic rheumatism: A reappraisal. Int J Clin Rheumatol. 2013 Oct;8(5):569–577.
  6. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, et al. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol. 2000 Jan;27(1):41–46.

Related Articles

    Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

    Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…

    A Brief History of American Rheumatology

    In medicine, as in all other areas of human endeavor, we cannot really understand where we are if we don’t understand how we arrived here. American rheumatology traces its origins nine decades back to Europe, when the International Committee on Rheumatism was founded by Jan van Breeman in 1925 at a European meeting of medical…

    How to Recognize an Autoinflammatory Disorder

    Autoinflammatory disorders may involve genetic mutations of the inflammasome or an environmental trigger in a genetically susceptible host. Dr. Jay Mehta discussed a practical, clinical approach to caring for patients with autoinflammatory disorders, such as periodic fever syndromes, during the 2022 ACR Education Exchange.